Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Change in Receivables (2016 - 2025)

Avanos Medical (AVNS) has disclosed Change in Receivables for 13 consecutive years, with -$8.1 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 2600.0% to -$8.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$30.9 million through Dec 2025, down 568.18% year-over-year, with the annual reading at -$30.9 million for FY2025, 568.18% down from the prior year.
  • Change in Receivables hit -$8.1 million in Q4 2025 for Avanos Medical, down from -$700000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $18.7 million in Q4 2022 to a low of -$26.2 million in Q1 2023.
  • Historically, Change in Receivables has averaged -$1.4 million across 5 years, with a median of -$500000.0 in 2024.
  • Biggest five-year swings in Change in Receivables: surged 6133.33% in 2022 and later tumbled 2600.0% in 2025.
  • Year by year, Change in Receivables stood at $300000.0 in 2021, then soared by 6133.33% to $18.7 million in 2022, then plummeted by 148.13% to -$9.0 million in 2023, then soared by 96.67% to -$300000.0 in 2024, then crashed by 2600.0% to -$8.1 million in 2025.
  • Business Quant data shows Change in Receivables for AVNS at -$8.1 million in Q4 2025, -$700000.0 in Q3 2025, and $3.0 million in Q2 2025.